Interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation "PRIORITET-CHF": initial characteristics and treatment of the first included patients

Aim. To describe demographic and clinical laboratory characteristics, concomitant diseases and drug therapy of outpatients with heart failure (HF) in the Russian Federation.

Material and methods. An interim analysis of a prospective observational multicenter registry study of patients with chronic heart failure in the Russian Federation ("PRIORITET-CHF") was performed. The study included outpatients with HF followed by a general practitioner or cardiologist.

Results. Data from 6255 patients were analyzed (31,3% of the study sample; median age, 65 years; men, 65%). HF with reduced ejection fraction (HFrEF) was diagnosed in 42,4%, HF with preserved EF — in 31,9%. In addition, 57,4% of patients were characterized by NYHA class II HF. The most common causes of HF were hypertension, coronary artery disease, and atrial fibrillation or flutter. Of the concomitant diseases, doctors most often reported chronic kidney disease (CKD) (43,2%), obesity (37,8%) and diabetes (26,7%) in HF.

Conclusion. In the Russian Federation, among outpatients with HF, there was domination of men, HFrEF phenotype, NYHA class II. The relatively young mean age and frequent associations of HF with cardiovascular risk factors and diseases underscore the importance of timely prevention initiatives. The identified high proportion of patients with CKD requires special attention and separate analysis. Despite the relatively high prescription rate of certain classes of diseasemodifying therapy for HF, the prescription of optimal quadruple therapy and electrophysiological treatments for HFrEF is insufficient.

1. Savarese G, Becher PM, Lund LH, et al. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272-87. doi:10.1093/cvr/cvac013.

2. Polyakov DS, Fomin IV, Belenkov YuN, et al. Chronic heart failure in the Russian Federation: what has changed over 20 years of follow-up? Results of the EPOCH-CHF study. Kardiologiia. 2021;61(4):4-14. (In Russ.) doi:10.18087/cardio.2021.4.n1628.

3. Soloveva AE, Endubaeva GV, Avdonina NG, et al. ICD-10 code-based definition of heart failure in Saint Petersburg electronic health records: prevalence, health care utilization and outcomes. Russian Journal of Cardiology. 2021;26(S3):4621. (In Russ.) doi:10.15829/1560-4071-2021-4621.

4. Drapkina OM, Boytsov SA, Omelyanovskiy VV, et al. Socio-economic impact of heart failure in Russia. Russian Journal of Cardiology. 2021;26(6):4490. (In Russ.) doi:10.15829/1560-4071-2021-4490.

5. Oshchepkova EV, Lazareva NV, Satlykova DF, Tereshchenko SN. The First Results of the Russian Register of Chronic Heart Failure. Kardiologiia. 2015;55(5):22-8. (In Russ.) doi:10.18565/cardio.2015.5.22-28.

6. Ageev FT, Blankova ZN, Svirida ON, et al. The first results of advanced medical care for chronic heart failure in different regions of the Russian Federation. Part II: Application of the main drugs for chronic heart failure and dynamics of hospitalizations. Russian Cardiology Bulletin. 2023;18(2):29-34. (In Russ.) doi:10.17116/Cardiobulletin20231802129.

7. Gilyarevsky SR, Gavrilov DV, Gusev AV. Retrospective analysis of electronic health records of patients with heart failure: the first Russian experience. Russian Journal of Cardiology. 2021;26(5):4502. (In Russ.) doi:10.15829/1560-4071-2021-4502.

8. Lopatin YuM, Nedogoda SV, Arkhipov MV, et al. Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I.Russian Journal of Cardiology. 2021;26(4):4368. (In Russ.) doi:10.15829/1560-4071-2021-4368.

9. Sitnikova MY, Lyasnikova EA, Yurchenko AV, et al. Results of Russian Hospital Chronic Heart Failure Registry in Three Subjects of Russian Federation. Kardiologiia. 2015;55(10):5-13. (In Russ.). doi:10.18565/cardio.2015.10.5-13.

10. Shlyakhto EV, Belenkov YuN, Boytsov SA, et al. Prospective observational multicenter registry study of patients with heart failure in the Russian Federation (PRIORITETCHF): rationale, objectives and design of the study. Russian Journal of Cardiology. 2023;28(6):5456. (In Russ.) doi:10.15829/1560-4071-2023-5456. EDN LKSHVP.

11. 2020 Clinical practice guidelines for Chronic heart failure. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.) doi:10.15829/1560-4071-2020-4083.

12. Fomin IV. Сhronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016;(8):7-13. (In Russ.) doi:10.15829/1560-4071-2016-8-7-13.

13. Johansen ND, Vaduganathan M, Zahir D, et al. A Composite Score Summarizing Use and Dosing of Evidence-Based Medical Therapies in Heart Failure: A Nationwide Cohort Study. Circ Heart Fail. 2023;16(2):e009729. doi:10.1161/CIRCHEARTFAILURE.122.009729.

14. Stolfo D, Lund LH, Benson L, et al. Persistent High Burden of Heart Failure Across the Ejection Fraction Spectrum in a Nationwide Setting. J Am Heart Assoc. 2022;11(22):e026708. doi:10.1161/JAHA.122.026708.

15. Maggioni AP, Anker SD, Dahlström U, et al. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail. 2013;15(10):1173-84. doi:10.1093/eurjhf/hft134.

16. Komanduri S, Jadhao Y, Guduru SS, et al. Prevalence and risk factors of heart failure in the USA: NHANES 2013-2014 epidemiological follow-up study. J Community Hosp Intern Med Perspect. 2017;7(1):15-20. doi:10.1080/20009666.2016.1264696.

17. Shlyakhto EV, Zvartau NE, Villevalde SV, et al. Cardiovascular risk management system: prerequisites for developing, organization principles, target groups. Russian Journal of Cardiology. 2019;(11):69-82. (In Russ.) doi:10.15829/1560-4071-2019-11-69-82.

18. Shlyakhto EV. Classification of heart failure: focus on prevention. Russian Journal of Cardiology. 2023;28(1):5351. (In Russ.) doi:10.15829/1560-4071-2023-5351.

19. Tromp J, Ouwerkerk W, van Veldhuisen DJ, et al. A Systematic Review and Network MetaAnalysis of Pharmacological Treatment of Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2022;10(2):73-84. doi:10.1016/j.jchf.2021.09.004. Erratum in: JACC Heart Fail. 2022;10(4):295-6.

20. Fomin IV, Polyakov DS, Vaisberg AR. 25 years of chronic heart failure treatment in clinical practice in the russian federation — are we doing everything right in 2022? Medical Almanac. 2022;(4):27-37. (In Russ.)

21. Van Spall HGC, Fonarow GC, Mamas MA. Underutilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change? J Am Coll Cardiol. 2022;79(22):2214-8. doi:10.1016/j.jacc.2022.03.351.

22. Lund LH, Carrero JJ, Farahmand B, et al. Association between enrolment in a heart failure quality registry and subsequent mortality-a nationwide cohort study. Eur J Heart Fail. 2017;19(9):1107-16. doi:10.1002/ejhf.762.